NEPG: The active pharmaceutical ingredient fosfomycin trometamol has received CEP certification
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Northeast Pharmaceutical announced that the company recently received the Certificate of Suitability for European Pharmacopoeia (referred to as "CEP Certificate") issued by the European Medicines Agency. The relevant raw material name is Fosfomycin Trometamol. Fosfomycin Trometamol is an antibiotic used for respiratory infections, lower urinary tract infections such as cystitis, urethritis, and intestinal infections, as well as skin and soft tissue infections caused by sensitive pathogenic bacteria
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments